Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> SANOFI Latest News

5 HOURS AGO - Reuters

A Must Read - Share

Sanofi sees first dengue vaccine filings in first quarter of 2015

PARIS (Reuters) - Sanofi expects to submit regulatory applications for the world's first dengue vaccine in the first quarter of 2015 and the French drugmaker could start selling the first batches at the end of that year, CEO Chris Viehbacher said on Thursday.

Tags: Sanofi sees first dengue vaccine filings in first quarter of 2015,  Sanofi Latest News

11 HOURS AGO - Yahoo! News

A Must Read - Share

Sanofi lifts profit forecast as second quarter beats expectations

By Natalie Huet PARIS (Reuters) - French drugmaker Sanofi raised its full-year profit forecast on Thursday as it posted stronger than expected quarterly earnings, driven by its rare disease and diabetes businesses and higher sales in emerging markets. Shares in Sanofi, which have underperformed the rest of the European pharmaceutical industry after a string of disappointing results last year, rose ...

Tags: Sanofi lifts profit forecast as second quarter beats expectations,  Sanofi Latest News

17 HOURS AGO - Wall Street Journal

A Must Read - Share

Drug Firms Buy $67.5 Million Voucher to Speed FDA Review

Regeneron Pharmaceuticals and Sanofi are spending $67.5 million to buy a special voucher held by BioMarin Pharmaceuticals in a bid to hasten regulatory review of their new cholesterol drug.

Tags: Drug Firms Buy $67.5 Million Voucher to Speed FDA Review,  Sanofi Latest News

23 HOURS AGO - Yahoo! News

A Must Read - Share

Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints

By Ransdell Pierson and Natalie Huet NEW YORK/PARIS (Reuters) - A new drug being developed by Sanofi SA and Regeneron Pharmaceuticals Inc significantly cut cholesterol in nine late-stage clinical trials, the companies said on Wednesday, and provided the first glimpse of its potential to prevent heart attacks and strokes. The injectable drug, alirocumab, is from a new class of medicines ...

Tags: Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints,  Sanofi Latest News

JUL 30, 2014 - Yahoo! News

A Must Read - Share

Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials

By Natalie Huet PARIS (Reuters) - A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday. The injectable drug, called alirocumab, is from a promising new class of medicines, called PCSK9 inhibitors, also being developed by Amgen ...

Tags: Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials,  Sanofi Latest News